![]() | Up a level |
Arshad, Usman ORCID: 0000-0003-1586-1885, Sutton, Paul A, Ashford, Marianne B, Treacher, Kevin E, Liptrott, Neill J
ORCID: 0000-0002-5980-8966, Rannard, Steve P
ORCID: 0000-0002-6946-1097, Goldring, Christopher E and Owen, Andrew
ORCID: 0000-0002-9819-7651
(2020)
Critical considerations for targeting colorectal liver metastases with nanotechnology.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 12 (2).
Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman
ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee
ORCID: 0000-0001-9448-8876, Curley, Paul
ORCID: 0000-0003-4596-2708, Neary, Megan
ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J
ORCID: 0000-0002-5980-8966, Valentijn, Anthony et al (show 13 more authors)
(2020)
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY.
Rajoli, Rajith Kr, Pertinez, Henry, Arshad, Usman, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul, Neary, Megan, Sharp, Joanne, Liptrott, Neill J, Valentijn, Anthony et al (show 13 more authors)
(2020)
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.
medRxiv : the preprint server for health sciences.
Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee
ORCID: 0000-0001-9448-8876, Rajoli, Rajith Kr
ORCID: 0000-0002-6015-5712, Curley, Paul
ORCID: 0000-0003-4596-2708, Neary, Megan
ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J
ORCID: 0000-0002-5980-8966, Valentijn, Anthony et al (show 12 more authors)
(2020)
Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
Clinical pharmacology and therapeutics.
Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee, Rajoli, Rajith KR, Curley, Paul
ORCID: 0000-0003-4596-2708, Neary, Megan
ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill, Valentijn, Anthony et al (show 11 more authors)
(2020)
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics.